Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
WHO Traditional Medicine Strategy: 2002-2005
(2002; 70 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentAcknowledgements
View the documentAcronyms, abbreviations and WHO Regions
Open this folder and view contentsKey points: WHO Traditional Medicine Strategy 2002 - 2005
Open this folder and view contentsChapter One: Global review
Open this folder and view contentsChapter Two: Challenges
Open this folder and view contentsChapter Three: The current role of WHO
Open this folder and view contentsChapter Four: International and national resources for traditional medicine
Open this folder and view contentsChapter Five: Strategy and plan of action 2002 - 2005
View the documentAnnex One: List of WHO Collaborating Centres for Traditional Medicine
Open this folder and view contentsAnnex Two: Selected WHO publications and documents on traditional medicine
View the documentReferences
View the documentBack Cover


This strategy was developed by WHO Headquarters and Regional Office staff working in essential drugs and medicines policy, in consultation with other WHO programme staff and with key development partners. It was then finalized in consultation with representatives from Member States, the wider UN family, nongovernmental and other international organizations, WHO Collaborating Centres for Traditional Medicine and WHO Expert Committees.

It covers country, regional, interregional and global work, and builds on discussions held during the WHO Consultation on Methodologies for Research and Evaluation of Traditional Medicine (11 - 14 April 2000) attended by experts in traditional medicine, as well as by WHO Headquarters and Regional Office staff working in traditional medicine. The meeting was followed by a series of conference calls between WHO Headquarters and Regional Offices, as well as conference calls with Member States and UN partners, to review drafts of the WHO Traditional Medicines Strategy 2002 - 2005.

WHO gratefully acknowledges the active participation and constructive comments received from members of the global extended medicines family including:

Member States: Armenia (E. Gabrielyan), Australia (G. Morrison), Belgium (J. Laruelle), Canada (Y. Bergevin, P. Chan), China (M. Chan, T. Leung, L. Peilong), Denmark (P. Rockhold), Germany (K. Keller), Ghana (E. Mensah), India (S. Chandra), Indonesia (K. Ritiasa), Italy (P. Procacci), Iran (M. Cheraghali), Japan (A. Yokomaku), Netherlands (M. ten Ham), Nigeria (T. Fakeye), Norway (O. Christiansen, E. Salvesen), Pakistan (F. Chowdhary), Republic of Korea (H.W. Han), Sweden (A. Nordström), Thailand (M.N. Songkhla), United Kingdom (J. Lambert), United States (B. Clay, L. Vogel), Viet Nam (L. Van Truyen), Zimbabwe (L. Matondo).

Other UN and multilateral agencies: European Commission (L. Fransen), UNAIDS (J. Perriens), UNDP (M. Bali), UNESCO (M-F. Roudil), WIPO (S. Bhatti), World Bank (R. Govindaraj).

Nongovernmental organizations and foundations: Ford Foundation (V. Davis Floyd), Islamic Organization for Medicinal Sciences (A. Awady), John D. and Catherine T. MacArthur Foundation (D. Martin), Rockefeller Foundation (A. So), WSMI (H. Cranz, J. Reinstein), Li Ka Shing Foundation (K. Lo).

WHO Collaborating Centres for Traditional Medicine: National Center for Complementary and Alternative Medicine, Bethesda (N. Hazleton), University of Illinois at Chicago, Chicago (N. Farnsworth).

WHO Expert Committees and Panels: F. Takaku, D. Jamison.

WHO Regional Offices: AFRO (O. Kasilo, E. Samba), AMRO/PAHO (G. Alleyne, C. Borras, R. D'Alessio, S. Land, D. López-Acuña, J.C. Silva), EMRO (H. Gezairy, P. Graaff, A. Salih), EURO (M. Danzon, K. de Joncheere), SEARO (P. Abeykoon, U.M. Rafei, K. Shein), WPRO (K. Chen, S. Omi).

WHO Headquarters (Department of Essential Drugs and Medicines Policy): G. Baghdadi, A. Creese, J. Graham, H. Hogerzeil, Y. Maruyama, J. Quick, L. Ragö, J. Sawyer, G. Velásquez, D. Whitney, X. Zhang.

WHO Headquarters (other programmes): O.B.R. Adams (EIP/OSD), A.D.A.S. Alwan (NMH/MNC), A. Asamoa-Baah (EGB), R. Bengoa (NMH/CCH), J. Cai (WKC), J. Frenk (EIP), D. Heymann (CDS), Y. Kawaguchi (WKC), B. Kean (EGB/ECP), A. Kern (GMG), M. T. Mbizvo (FCH/RHR), A. Mboi (FCH/WMH), D. Nabarro (DGO), B. Saraceno (NMH/MSD), Y. Suzuki (HTP), D. Tarantola (Senior Policy Adviser), T. Türmen (FCH), E. M. Wallstam (SDE/HSD), D. Yach (NMH). T. Falkenberg, J. Sawyer and X. Zhang drafted the strategy and J. Graham, J.D. Quick, J. Sawyer, P. Thorpe, D. Whitney and X. Zhang undertook revision and editing. V.A. Lee and Y. Maruyama provided secretarial support.


to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017